Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Antti Siltanen

Analyst

Antti Siltanen portrait

Coverage

Herantis PharmaNexstimFaron PharmaceuticalsNightingale HealthBioretecBiohitOrionModulight

Latest content

ShowingAll content types

Orion Q4'25: En begivenhedsløs afslutning på et år med stærk vækst

Research 13.02.2026, 06.00 by Antti Siltanen
Orion

Herantis strengthened its financial position via directed share issue

Analyst Comment 12.02.2026, 08.39 by Antti Siltanen
Herantis Pharma

Faron updated its research and financing plans

Analyst Comment 12.02.2026, 09.24 by Antti Siltanen
Faron Pharmaceuticals

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Biohit H2'25: Strong earnings – more moderate growth outlook

Research 12.02.2026, 09.16 by Antti Siltanen
Biohit

Bioretec Q4'25 preview: Expectations for the rest of the year are at a moderate level

Analyst Comment 11.02.2026, 07.53 by Antti Siltanen
Bioretec

Faron Pharmaceuticals: From financing crossroads towards share issue

Research 10.02.2026, 08.35 by Antti Siltanen
Faron Pharmaceuticals

A step forward for Nightingale in New York

Analyst Comment 10.02.2026, 07.50 by Antti Siltanen
Nightingale Health

Orion Q4'25 preview: Royalties og milepælsbetaling gav medvind i slutningen af året

Analyst Comment 09.02.2026, 06.00 by Antti Siltanen
Orion

Biohit Q4'25 preview: Back on the growth path from the middle of a sandstorm

Analyst Comment 06.02.2026, 08.27 by Antti Siltanen
Biohit

Aiforia's new clinical AI solution for gastric cancer diagnostics

Analyst Comment 03.02.2026, 07.32 by Antti Siltanen
Aiforia Technologies
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.